Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
Neurology and therapy(2023)
摘要
The safety and PD of risdiplam in patients who were previously treated were consistent with those of treatment-naïve patients.
更多查看译文
关键词
Evrysdi,Pharmacodynamics,Risdiplam,Safety,Spinal muscular atrophy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要